No Detail Found!

Integrating eugenol with intensive care in leukemia patients: exploration of pro-apoptotic potential against HL-60, human leukemia cell line

Author(s)
Hafiz Muhammad Haseeb Khaliq Department of Molecular Pathology and Genomics, Forman Christian College,Lahore,Pakistan
Rabia Bughio Department of Anatomy, Liaquat University of Medical and Health Sciences,Jamshoro,Pakistan
Pirya Nangdev Department of Anatomy, Bilawal Medical College, Liaquat University of Medical and Health Sciences,Jamshoro,Pakistan
Owais Aziz Department of Molecular Pathology and Genomics, Forman Christian College,Lahore,Pakistan
Warda Javed Department of Botany, Government College University,Faisalabad,Pakistan
Abstract
Objective: The objective of this in-vitro study was to explore the pro-apoptotic potential of eugenol (4-allyl-2methoxyphenol) on Human Leukemia-60 (HL-60) cell line as a potent phytochemical in intensive care setting to leukemia patients. Methodology: After formal approval by all of the respective ethical committees, this study was simultaneously conducted at all respective institutional departments. The study included culturing HL-60 cell line and its treatment with serial concentrations of eugenol for calculation of subsequent IC50 values (half-maximal inhibitory concentration) via MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide] assay, expression analysis of gene, comparative analysis of relative gene fold (Intrinsic Biomarkers Caspase-3, Caspase-9) as apoptosis mediator markers followed by RT-qPCR. Cellular apoptotic morphology was confirmed via Hoechst 333258 staining. Results: For HL-60 cell line, the IC50 of eugenol (14.1 uM) showed high gene expression of pro-apoptotic biomarkers (Caspase-3 and Caspase-9). Hoechst 333258 staining showed prominent apoptotic bodies leading to nuclear fragmentations. Conclusion: Eugenol proved to possess robust pro-apoptotic potential leading to diagnostic efficacy against leukemia HL-60 cell line. Further studies would help in identifying key mechanisms by which eugenol exhibits anti-cancer potential against HL-60 cell lines. Abbreviations: HL-60 - Human Leukemia-60; IC50 - Half-Maximal Inhibitory Concentration
Publication Details
Page(s) 871-875
Published Journal: Anaesthesia, Pain and Intensive Care, Volume: 28, Issue: 5, Year: 2024

Request the full text from PASTIC

Keywords
Intensive care, Eugenol, Anti-Cancer Mechanisms, Natural Chemotherapeutics, Pro-apoptotic Effects, HL-60
References
Yoo CB,Han KT,Cho KS,Ha J,Park HJ,Nam JH .2005 .Eugenol isolated from the essential oil of Eugenia caryophyllata induces a reactive oxygen species-mediated apoptosis in HL-60 human promyelocytic leukemia cells. Cancer Lett, 225(1) : 41-52.
.2004 .. , 11 : .
Zari AT,Zari TA,Hakeem KR .2021 .Anticancer properties of eugenol: A review. Molecules, 26(23) : 7407.
.2018 .. , 57(3) : 333-46.
. .Regulation of ROS-dependent JNK pathway by 2'- hydroxycinnamaldehyde inducing apoptosis in human promyelocytic HL-60 leukemia cells. Pharmaceutics., : .
.2021 .. , 13(11) : 1794.
Cheng Y,Li S,Gao L,Zhi K,Ren W. .2021 .The molecular basis and therapeutic aspects of cisplatin resistance in oral squamous cell carcinoma. Front Oncol, 11 : 761379.
Kilic U,Sahin K,Tuzcu M,Basak N,Orhan C,Elibol-Can B .2015 .Enhancement of cisplatin sensitivity in human cervical cancer: epigallocatechin-3-gallate. Front Nutr, 1 : 28.
.2014 .. , : .
Padhy I,Paul P,Sharma T,Banerjee S,Mondal A .2022 .Molecular mechanisms of action of eugenol in cancer: Recent trends and advancement. Life, 12(11) : 1795.
Phytomedicine .2022 .. , 107 : 154456.
Cragg GM,Pezzuto JM .2016 .Natural products as a vital source for the discovery of cancer chemotherapeutic and chemopreventive agents. Med Princ Pract, 25(Suppl 2) : 41-59.
Kunnumakkara AB,Sailo BL,Banik K,Harsha C,Prasad S,Gupta SC,Bharti AC,Aggarwal BB .2018 .Chronic diseases, inflammation, and spices: how are they linked. J Transl Med, 16(1) : 14.
Sztiller-Sikorska M,Jakubowska J,Wozniak M,Stasiak M,Czyz M. . .A non-apoptotic function of caspase-3 in pharmacologicallyinduced differentiation of K562 ells. Br J Pharmacol., : .
.2009 .. , 00333(8) : 5381-62.
Jafri A,Siddiqui S,Rais J,Ahmad MS,Kumar S,Jafar T .2019 .Induction of apoptosis by piperine in human cervical adenocarcinoma via ROS mediated mitochondrial pathway and caspase-3 activation. , 18 : 1928-64.
Aru B,Güzelmeric E,Akgül A,Demirel GY,Kırmızıbekmez H .2019 .Antiproliferative activity of chemically characterized propolis from Turkey and its mechanisms of action. Chem Biodivers, 16(7) : .
Al-Rawashde FA,Johan MF,Taib WRW,Ismail I,Johari SATT,Almajali B .2021 .Thymoquinone inhibits growth of acute myeloid leukemia cells through reversal SHP-1 and SOCS-3 hypermethylation: In vitro and in silico evaluation. Pharmaceuticals (Basel), 14(12) : 1287.
Shehabeldine AM,Doghish AS,El-Dakroury WA,Hassanin MMH,Al-Askar AA,AbdElgawad H .2023 .Antimicrobial, antibiofilm, and anticancer activities of Syzygium aromaticum essential oil nanoemulsion. Molecules, 28(15) : 5812.
Hu BH,Zheng GL .2008 .Membrane disruption: an early event of hair cell apoptosis induced by exposure to intense noise. Brain Res, 08 : 107-18.
Wadia JS,Chalmers-Redman RM,Ju WJ,Carlile GW,Phillips JL,Fraser AD .1998 .Mitochondrial membrane potential and nuclear changes in apoptosis caused by serum and nerve growth factor withdrawal: time course and modification by (-)- deprenyl. J Neurosci, 18(3) : 00932-47.
Shi X,Zhang W,Bao X,Liu X,Yang M,Yin C .2023 .Eugenol modulates the NOD1-NF-κB signaling pathway via targeting NFκB protein in triple-negative breast cancer cells. Front Endocrinol (Lausanne), 14 : 1136067.
Maqbool M,Bekele F,Fekadu G .2022 .Treatment strategies against triple-negative breast cancer: An updated review. Breast Cancer (Dove Med Press), 14 : 15-24.
Hussain A,Brahmbhatt K,Priyani A,Ahmed M,Rizvi TA,Sharma C .2010 .Eugenol enhances the chemotherapeutic potential of gemcitabine and induces anticarcinogenic and antiinflammatory activity in human cervical cancer cells. Cancer Biother Radiopharm, 26(5) : 519-27.
0

Citations

0

Downloads

36

Views